Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05285605 · ClinicalTrials.gov registry record
Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 75
- Enrollment target
NCT05285605: Completed study, sponsored by Northwestern University.
NCT05285605 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05285605 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
This study will entail provision of ulipristal acetate (UPA) for emergency contraception (EC) in the postpartum period for patients who have not chosen to initiate a highly effective form of contraception and study the use of EC overall as well as with regards to participants' perception of reproductive autonomy. The investigators hypothesize that providing an advance supply of EC will increase use and decrease barriers to use. Additionally, the investigators hypothesize that, with thorough EC counseling, participants will develop an increased knowledge base of EC. With increased use and knowledge, the investigators hypothesize that participants will experience greater reproductive autonomy over their contraceptive decisions.
Primary Outcome
Uses a modified reproductive autonomy scale to measure participants' sense of reproductive autonomy. Highest score is 40 which is associated with greater reproductive autonomy and lowest score is 0.
Interventions
- DRUG Ulipristal Acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2024-01-22 |
What the finished NCT05285605 record still lists
NCT05285605 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ulipristal Acetate is the first listed.
NCT05285605 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05285605 about?
NCT05285605 is a clinical study titled "Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy". This study will entail provision of ulipristal acetate (UPA) for emergency contraception (EC) in the postpartum period for patients who have not chosen to initiate a highly effective form of contraception and study the use of EC overall as well as with regards to participants' perception of reproduc...
What is the current status of trial NCT05285605?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2022-03-01. Estimated completion is 2024-01-22.
What interventions are being tested in trial NCT05285605?
The interventions under investigation include: Ulipristal Acetate (DRUG).
Who is sponsoring clinical trial NCT05285605?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI